Diagnosis and management of migraine in ten steps

[1]  R. Lipton,et al.  Migraine: epidemiology and systems of care , 2021, The Lancet.

[2]  N. Hadjikhani,et al.  Migraine: disease characterisation, biomarkers, and precision medicine , 2021, The Lancet.

[3]  D. Dodick,et al.  Migraine: integrated approaches to clinical management and emerging treatments , 2021, The Lancet.

[4]  Shuu-Jiun Wang,et al.  Tension-type headache , 2021, Nature Reviews Disease Primers.

[5]  M. Ashina.  Migraine. , 2020, The New England journal of medicine.

[6]  L. Bendtsen,et al.  Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial. , 2020, JAMA neurology.

[7]  S. Aurora,et al.  The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review , 2020, Headache.

[8]  H. Diener,et al.  European Academy of Neurology guideline on the management of medication‐overuse headache , 2020, European journal of neurology.

[9]  D. Buse,et al.  Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies , 2020, Cephalalgia : an international journal of headache.

[10]  H. Diener.  The Risks or Lack Thereof of Migraine Treatments in Vascular Disease , 2020, Headache.

[11]  Zoé E. Headley.  Contents 1 , 2020, Reinforced Plastics.

[12]  S. Silberstein,et al.  Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence‐Based Guideline , 2019, Headache.

[13]  L. Wilkins.  Practice guideline update summary: Acute treatment of migraine in children and adolescents , 2019, Neurology.

[14]  S. Aurora,et al.  Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials , 2019, European journal of neurology.

[15]  R. Lipton,et al.  Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial. , 2019, JAMA.

[16]  A. Charles,et al.  Targeting calcitonin gene-related peptide: a new era in migraine therapy , 2019, The Lancet.

[17]  R. Lipton,et al.  Pathophysiology, prevention, and treatment of medication overuse headache , 2019, The Lancet Neurology.

[18]  H. Diener,et al.  Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial , 2019, The Lancet.

[19]  S. Powers,et al.  Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention , 2019, Neurology.

[20]  R. Lipton,et al.  Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study , 2019, Headache.

[21]  M. Moskowitz,et al.  Migraine and the trigeminovascular system—40 years and counting , 2019, The Lancet Neurology.

[22]  R. Lipton,et al.  Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. , 2019, The New England journal of medicine.

[23]  M. Case,et al.  Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine , 2019, Brain : a journal of neurology.

[24]  G. Serafini,et al.  Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications , 2019, The Journal of Headache and Pain.

[25]  Y. Hayashino,et al.  Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis , 2019, PloS one.

[26]  U. Reuter,et al.  Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[27]  Natalie Govind.  Acupuncture for the prevention of episodic migraine , 2019, Research in nursing & health.

[28]  M. Ferrari,et al.  Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial , 2019, Brain : a journal of neurology.

[29]  S. Sacco,et al.  European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention , 2019, The Journal of Headache and Pain.

[30]  R. Lipton,et al.  Migraine Progression: A Systematic Review , 2018, Headache.

[31]  M. Obermann,et al.  Red and orange flags for secondary headaches in clinical practice , 2018, Neurology.

[32]  D. Mccrory,et al.  Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis , 2018, Pain.

[33]  S. Janković,et al.  Translation and Transcultural Validation of Migraine Screening Questionnaire (MS-Q) , 2018, Medical archives.

[34]  D. Bereczki,et al.  The validation of the Hungarian version of the ID-migraine questionnaire , 2018, The Journal of Headache and Pain.

[35]  R. Lipton,et al.  Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study , 2018, Headache.

[36]  M. Ferrari,et al.  Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study , 2018, The Lancet.

[37]  Ivy Shiue,et al.  Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[38]  P. Goadsby,et al.  Biological insights from the premonitory symptoms of migraine , 2018, Nature Reviews Neurology.

[39]  M. Marmura.  Triggers, Protectors, and Predictors in Episodic Migraine , 2018, Current Pain and Headache Reports.

[40]  S. Sacco,et al.  Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation , 2018, The Journal of Headache and Pain.

[41]  J. Dogné,et al.  Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation , 2018, The Journal of Headache and Pain.

[42]  S. Powers,et al.  Paediatric migraine: evidence-based management and future directions , 2018, Nature Reviews Neurology.

[43]  L. Bendtsen,et al.  Increased pain sensitivity in migraine and tension‐type headache coexistent with low back pain: A cross‐sectional population study , 2018, European journal of pain.

[44]  R. Lipton,et al.  The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility , 2018, The Journal of Headache and Pain.

[45]  T. Steiner,et al.  Poor medical care for people with migraine in Europe – evidence from the Eurolight study , 2018, The Journal of Headache and Pain.

[46]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[47]  R. Lipton,et al.  Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design , 2017, The Journal of Headache and Pain.

[48]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[49]  T. Pincus,et al.  Prognostic factors for chronic headache , 2017, Neurology.

[50]  R. Evans,et al.  Incidental Findings and Normal Anatomical Variants on MRI of the Brain in Adults for Primary Headaches , 2017, Headache.

[51]  J. Olesen,et al.  The migraine postdrome , 2016, Neurology.

[52]  T. Steiner,et al.  Headache, depression and anxiety: associations in the Eurolight project , 2016, The Journal of Headache and Pain.

[53]  P. Goadsby,et al.  The migraine postdrome. , 2016, Current opinion in neurology.

[54]  S. Cousins,et al.  Psychological interventions for migraine: a systematic review , 2016, Journal of Neurology.

[55]  R. Moore,et al.  Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults. , 2016, The Cochrane database of systematic reviews.

[56]  A. May,et al.  Efficacy of interventions used by physiotherapists for patients with headache and migraine—systematic review and meta-analysis , 2016, Cephalalgia : an international journal of headache.

[57]  C. Lundqvist,et al.  Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial , 2016, Journal of Neurology.

[58]  J. Olesen,et al.  European headache federation consensus on technical investigation for primary headache disorders , 2015, The Journal of Headache and Pain.

[59]  S. Sacco,et al.  Migraine in pregnancy , 2015, The Journal of Headache and Pain.

[60]  S. Silberstein,et al.  Late-life migraine accompaniments: A narrative review , 2015, Cephalalgia : an international journal of headache.

[61]  D. Dodick,et al.  Adherence to oral migraine-preventive medications among patients with chronic migraine , 2015, Cephalalgia : an international journal of headache.

[62]  C. Clarke,et al.  Botulinum toxins for the prevention of migraine in adults. , 2015, The Cochrane database of systematic reviews.

[63]  L. Stovner,et al.  Pharmacological treatment of migraine during pregnancy and breastfeeding , 2015, Nature Reviews Neurology.

[64]  R. Lipton,et al.  Prevalence of neck pain in migraine and tension-type headache: A population study , 2015, Cephalalgia : an international journal of headache.

[65]  R. Lipton,et al.  Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine , 2015, Neurology.

[66]  R. Lipton,et al.  Methodological Issues in Studying Trigger Factors and Premonitory Features of Migraine , 2014, Headache.

[67]  S. Silberstein,et al.  Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment , 2014, Expert opinion on pharmacotherapy.

[68]  C. Lundqvist,et al.  Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[69]  Elizabeth Salisbury-Afshar,et al.  Topiramate for the prophylaxis of episodic migraine in adults. , 2014, American family physician.

[70]  L. Stovner,et al.  A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study , 2014, Cephalalgia : an international journal of headache.

[71]  R. Moore,et al.  Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews. , 2014, The Cochrane database of systematic reviews.

[72]  J. Burke,et al.  Headaches and neuroimaging: high utilization and costs despite guidelines. , 2014, JAMA internal medicine.

[73]  C. Lundqvist,et al.  Prevalence of menstrual migraine: A population-based study , 2014, Cephalalgia : an international journal of headache.

[74]  P. Aveyard,et al.  Should we educate about the risks of medication overuse headache? , 2014, The Journal of Headache and Pain.

[75]  M. Melbye,et al.  Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. , 2013, Journal of the American Medical Association (JAMA).

[76]  E. Chronicle,et al.  Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. , 2013, The Cochrane database of systematic reviews.

[77]  R. Lipton,et al.  The Headache Under-Response to Treatment (HURT) Questionnaire: Assessment of utility in headache specialist care , 2013, Cephalalgia : an international journal of headache.

[78]  R. Lipton,et al.  HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability, validity and clinical utility of the Arabic version , 2013, The Journal of Headache and Pain.

[79]  R. Lipton,et al.  Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study , 2013, The Journal of Headache and Pain.

[80]  R. Lipton,et al.  Migraine headache is present in the aura phase – a prospective study , 2013, The Journal of Headache and Pain.

[81]  R. Lipton,et al.  Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study , 2012, Headache.

[82]  R. Moore,et al.  DICLOFENAC WITH OR WITHOUT AN ANTIEMETIC FOR ACUTE MIGRAINE HEADACHES IN ADULTS , 2012, The Cochrane database of systematic reviews.

[83]  S. Silberstein,et al.  Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.

[84]  Peter J. Goadsby,et al.  Chronic migraine—classification, characteristics and treatment , 2012, Nature Reviews Neurology.

[85]  G. Mick,et al.  Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study , 2012, Cephalalgia.

[86]  M. Russell,et al.  Are Menstrual and Nonmenstrual Migraine Attacks Different? , 2011, Current pain and headache reports.

[87]  S. Tepper,et al.  Unusual Headaches in the Elderly , 2011, Current pain and headache reports.

[88]  T. Steiner,et al.  Recommendations for headache service organisation and delivery in Europe , 2011, The Journal of Headache and Pain.

[89]  G. Coppola,et al.  Neurophysiological tests and neuroimaging procedures in non‐acute headache (2nd edition) , 2011, European journal of neurology.

[90]  L. Bendtsen,et al.  What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? , 2011, The Journal of Headache and Pain.

[91]  J. Couch.  Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache , 2011, Headache.

[92]  Dorothy Becher,et al.  Tricyclic antidepressants and headaches: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[93]  R. Lipton,et al.  Global prevalence of chronic migraine: A systematic review , 2010, Cephalalgia : an international journal of headache.

[94]  I. Martins,et al.  Validation of the Portuguese Version of ID‐Migraine™ , 2010, Headache.

[95]  R. Lipton,et al.  Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[96]  A. Hershey,et al.  Current approaches to the diagnosis and management of paediatric migraine , 2010, The Lancet Neurology.

[97]  R. Lipton,et al.  Topiramate Treatment of Chronic Migraine: A Randomized, Placebo‐Controlled Trial of Quality of Life and Other Efficacy Measures , 2009, Headache.

[98]  J. Buring,et al.  Migraine frequency and risk of cardiovascular disease in women , 2009, Neurology.

[99]  K. Kolodner,et al.  Validity and Reliability of the Migraine-Treatment Optimization Questionnaire , 2009, Cephalalgia : an international journal of headache.

[100]  S. Evers,et al.  Placebo Efficacy in Childhood and Adolescence Migraine: An Analysis of Double-Blind and Placebo-Controlled Studies , 2009, Cephalalgia : an international journal of headache.

[101]  J. Hulihan,et al.  Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. , 2009, Clinical therapeutics.

[102]  R. Lipton,et al.  Excessive opioid use and the development of chronic migraine , 2009, PAIN®.

[103]  P. Koehler,et al.  History of the Use of Ergotamine and Dihydroergotamine in Migraine From 1906 and Onward , 2008, Cephalalgia : an international journal of headache.

[104]  S. Silberstein,et al.  Migraine in pregnancy , 2008, BMJ : British Medical Journal.

[105]  S. Evers,et al.  The Incidence and Prevalence of Cluster Headache: A Meta-Analysis of Population-Based Studies , 2008, Cephalalgia : an international journal of headache.

[106]  P J Goadsby,et al.  Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan , 2008, Cephalalgia : an international journal of headache.

[107]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[108]  M. Dahlem,et al.  Family history of migraine , 2007 .

[109]  R. Jensen,et al.  Assessment of Headache Diagnosis. A Comparative Population Study of a Clinical Interview With a Diagnostic Headache Diary , 2007, Cephalalgia : an international journal of headache.

[110]  R. Lipton,et al.  Age-dependent prevalence and clinical features of migraine , 2006, Neurology.

[111]  R. Lipton,et al.  Migraine at all ages , 2006, Current pain and headache reports.

[112]  Martin Tegenthoff,et al.  Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial , 2006, The Lancet Neurology.

[113]  C. Dahlöf.  Infrequent or Non-Response to Oral Sumatriptan does not Predict Response to Other Triptans—Review of Four Trials , 2006, Cephalalgia : an international journal of headache.

[114]  M. Láinez,et al.  Development and Validation of the Migraine Screen Questionnaire (MS‐Q) , 2005, Headache.

[115]  B. Fierro,et al.  A validation study of an Italian version of the ID Migraine: preliminary results , 2005, The Journal of Headache and Pain.

[116]  M. Buchem,et al.  Neurophysiological tests and neuroimaging procedures in non‐acute headache: guidelines and recommendations , 2004, European Journal of Neurology.

[117]  R. Lipton,et al.  A self-administered screener for migraine in primary care , 2003, Neurology.

[118]  J. Olesen,et al.  Eletriptan for the Treatment of Migraine in Patients with Previous Poor Response or Tolerance to Oral Sumatriptan , 2003, Cephalalgia : an international journal of headache.

[119]  R. Lipton,et al.  Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study , 2001, Headache.

[120]  J. Olesen,et al.  Evidence of a genetic factor in migraine with aura: A population‐based Danish twin study , 1999, Annals of neurology.

[121]  J. Olesen,et al.  The Family History of Migraine. Direct Versus Indirect Information , 1996, Cephalalgia : an international journal of headache.

[122]  J. Olesen,et al.  A nosographic analysis of the migraine aura in a general population. , 1996, Brain : a journal of neurology.

[123]  V. Pfaffenrath.  [Treatment of migraine attacks with sumatriptan]. , 1993, Fortschritte der Medizin.

[124]  J. Hilden,et al.  Familial occurrence of migraine without aura and migraine with aura , 1993, Neurology.

[125]  J. Olesen,et al.  Migraine With Aura and Migraine Without Aura: An Epidemiological Study , 1992, Cephalalgia : an international journal of headache.

[126]  L. Milne.  Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. , 1992, The New England journal of medicine.

[127]  M. Arnold.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.

[128]  M. Danhof,et al.  Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials , 2018, Clinical Pharmacokinetics.

[129]  T. Steiner,et al.  EHF-LTB Aids to management of headache disorders in primary care (2nd edition) , 2017 .

[130]  R. Moore,et al.  Aspirin with or without an antiemetic for acute migraine headaches in adults. , 2010, The Cochrane database of systematic reviews.

[131]  R. Moore,et al.  Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. , 2010, The Cochrane database of systematic reviews.

[132]  R. Moore,et al.  Ibuprofen with or without an antiemetic for acute migraine headaches in adults. , 2010, The Cochrane database of systematic reviews.

[133]  G. Millman,et al.  Migraine headache in children. , 2006, Clinical evidence.

[134]  L. Stovner,et al.  Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. , 2003 .

[135]  J. Olesen,et al.  Epidemiology of headache in a general population--a prevalence study. , 1991, Journal of clinical epidemiology.

[136]  T. Pincus,et al.  Prognostic factors for chronic headache A systematic review , 2022 .